Dr. Christine Read Gonzales, MD

Dr. Gonzales practices at Retina & Vitreous Center of Southern Oregon in Ashland, Oregon.

Dr. Gonzales' NPI, 1700809365, was assigned on July 25, 2006. Dr. Gonzales graduated from UCSF School of Medicine in 1995. Dr. Gonzales holds California license A68646.

Dr. Gonzales' primary practice is Retina & Vitreous Center of Southern Oregon, at 246 Catalina Dr, Ashland, OR 97520 in Jackson County. The practice phone is (541) 488-3192.

Dr. Gonzales' primary practice is Retina & Vitreous Center of Southern Oregon in Ashland, Oregon. Dr. Gonzales is also affiliated with Asante Ashland. Dmand AI also links Dr. Gonzales to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzales practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Gonzales' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Gonzales is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Gonzales' licenses on file in 2 states: California and Oregon.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and inflammation of iris among the conditions Dr. Gonzales treats.

CMS data shows 27,062 Medicare services from Dr. Gonzales across 24 procedure codes in 2024, for 830 Medicare patients. Medicare paid $2,438,916 for them. Every service was in an office.

CMS counts 830 Medicare patients who saw Dr. Gonzales in 2024. The largest group is 75 to 84, with 360 patients. 70% of them have high blood pressure, and 64% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gonzales' median patient age at 76, with 56% women.

In 2024, Dr. Gonzales wrote 362 Medicare Part D claims for 122 patients. 67% of them were for generic drugs. CMS names the drug for 307 of them, across 6 drugs with 11 or more claims each, at $6,975 in total drug cost. In 2023, CMS named 265 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gonzales for performance year 2024, reported as part of a group. Dr. Gonzales accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Gonzales, published from 2005 to 2011. The most frequent topics are Visual Acuity and Fluorescein Angiography. Dr. Gonzales has published most often in Retina. Dr. Gonzales' most frequent co-authors are Nancy Kunjukunju, MD, Michael M. Altaweel, MD and Amy Suzon Chappell, MD.

CMS Open Payments shows 51 general payments to Dr. Gonzales from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,139.

Dmand AI lists 2 awards for Dr. Gonzales, most recently Regional Top Doctor in 2014.

Dr. Gonzales graduated from UCSF School of Medicine in 1995. Dr. Gonzales is a member of AAO.

Dr. Gonzales is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.